{"id":"https://openalex.org/W1994714419","doi":"https://doi.org/10.4161/hv.27426","title":"Rationale for full-season dosing for passive antibody prophylaxis of respiratory syncytial virus","display_name":"Rationale for full-season dosing for passive antibody prophylaxis of respiratory syncytial virus","publication_year":2013,"publication_date":"2013-12-06","ids":{"openalex":"https://openalex.org/W1994714419","doi":"https://doi.org/10.4161/hv.27426","mag":"1994714419","pmid":"https://pubmed.ncbi.nlm.nih.gov/24316863","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4130285"},"language":"en","primary_location":{"id":"doi:10.4161/hv.27426","doi":"https://doi.org/10.4161/hv.27426","is_oa":true,"landing_page_url":"https://doi.org/10.4161/hv.27426","pdf_url":null,"source":{"id":"https://openalex.org/S2483136528","display_name":"Human Vaccines & Immunotherapeutics","issn_l":"2164-5515","issn":["2164-5515","2164-554X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Vaccines & Immunotherapeutics","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.4161/hv.27426","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048082779","display_name":"Doris Makari","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Doris Makari","raw_affiliation_strings":["MedImmune; Gaithersburg, MD USA","Gaithersburg, MD USA","MedImmune"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MedImmune; Gaithersburg, MD USA","institution_ids":[]},{"raw_affiliation_string":"Gaithersburg, MD USA","institution_ids":[]},{"raw_affiliation_string":"MedImmune","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036929595","display_name":"Paul A. Checchia","orcid":"https://orcid.org/0000-0003-0364-2052","observed_orcids":["https://orcid.org/0000-0003-0364-2052"]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]},{"id":"https://openalex.org/I4210147586","display_name":"Texas Children's Hospital","ror":"https://ror.org/05cz92x43","country_code":"US","type":"funder","lineage":["https://openalex.org/I4210147586"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul A Checchia","raw_affiliation_strings":["Texas Children's Hospital; Baylor College of Medicine; Houston, TX USA","Baylor College of Medicine","Houston, TX USA","Texas Children's Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Texas Children's Hospital; Baylor College of Medicine; Houston, TX USA","institution_ids":["https://openalex.org/I181547552","https://openalex.org/I4210147586"]},{"raw_affiliation_string":"Baylor College of Medicine","institution_ids":["https://openalex.org/I181547552"]},{"raw_affiliation_string":"Houston, TX USA","institution_ids":[]},{"raw_affiliation_string":"Texas Children's Hospital","institution_ids":["https://openalex.org/I4210147586"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036771694","display_name":"John P. DeVincenzo","orcid":"https://orcid.org/0000-0003-2655-344X","observed_orcids":["https://orcid.org/0000-0003-2655-344X"]},"institutions":[{"id":"https://openalex.org/I4210132574","display_name":"Children\u2019s Foundation","ror":"https://ror.org/03exer738","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I4210132574"]},{"id":"https://openalex.org/I4210156806","display_name":"Le Bonheur Children's Hospital","ror":"https://ror.org/056wg8a82","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210156806"]},{"id":"https://openalex.org/I75027704","display_name":"University of Tennessee at Knoxville","ror":"https://ror.org/020f3ap87","country_code":"US","type":"education","lineage":["https://openalex.org/I75027704"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"John DeVincenzo","raw_affiliation_strings":["Departments of Pediatrics; Microbiology, Immunology and Molecular Biology; University of Tennessee School of Medicine; Memphis, TN USA; Children's Foundation Research Institute; Le Bonheur Children's Hospital; Memphis, TN USA","Children's Foundation Research Institute","Departments of Pediatrics","Le Bonheur Children's Hospital","Memphis, TN USA","Microbiology, Immunology and Molecular Biology","University of Tennessee School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Pediatrics; Microbiology, Immunology and Molecular Biology; University of Tennessee School of Medicine; Memphis, TN USA; Children's Foundation Research Institute; Le Bonheur Children's Hospital; Memphis, TN USA","institution_ids":["https://openalex.org/I4210156806"]},{"raw_affiliation_string":"Children's Foundation Research Institute","institution_ids":["https://openalex.org/I4210132574"]},{"raw_affiliation_string":"Departments of Pediatrics","institution_ids":[]},{"raw_affiliation_string":"Le Bonheur Children's Hospital","institution_ids":["https://openalex.org/I4210156806"]},{"raw_affiliation_string":"Memphis, TN USA","institution_ids":[]},{"raw_affiliation_string":"Microbiology, Immunology and Molecular Biology","institution_ids":[]},{"raw_affiliation_string":"University of Tennessee School of Medicine","institution_ids":["https://openalex.org/I75027704"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5048082779"],"corresponding_institution_ids":[],"apc_list":{"value":2895,"currency":"EUR","value_usd":3175},"apc_paid":{"value":2895,"currency":"EUR","value_usd":3175},"fwci":0.1186,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":{"value":0.1431848,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"10","issue":"3","first_page":"607","last_page":"614"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11243","display_name":"Respiratory viral infections research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11243","display_name":"Respiratory viral infections research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10549","display_name":"Neonatal Respiratory Health Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11725","display_name":"Immunodeficiency and Autoimmune Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/respiratory-syncytial-virus","display_name":"respiratory syncytial virus","score":0.9010000228881836},{"id":"https://openalex.org/keywords/palivizumab","display_name":"palivizumab","score":0.9800000190734863},{"id":"https://openalex.org/keywords/rsv-hospitalization","display_name":"RSV hospitalization","score":0.7210000157356262},{"id":"https://openalex.org/keywords/preterm-infants","display_name":"preterm infants","score":0.8999999761581421},{"id":"https://openalex.org/keywords/late-preterm-infants","display_name":"late preterm infants","score":0.9539999961853027},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9010000228881836},{"id":"https://openalex.org/keywords/trough-concentration","display_name":"trough concentration","score":0.7509999871253967},{"id":"https://openalex.org/keywords/interpatient-variability","display_name":"interpatient variability","score":0.8399999737739563},{"id":"https://openalex.org/keywords/rsv-season","display_name":"RSV season","score":0.6439999938011169}],"concepts":[{"id":"https://openalex.org/C2778644256","wikidata":"https://www.wikidata.org/wiki/Q412765","display_name":"Palivizumab","level":3,"score":0.9966616630554199},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.898428201675415},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.638983964920044},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.5788132548332214},{"id":"https://openalex.org/C2781445406","wikidata":"https://www.wikidata.org/wiki/Q24802277","display_name":"Pneumovirinae","level":5,"score":0.41486066579818726},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.3616795539855957},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.2433885931968689},{"id":"https://openalex.org/C2780813555","wikidata":"https://www.wikidata.org/wiki/Q911129","display_name":"Paramyxoviridae","level":4,"score":0.20559072494506836},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.20135661959648132},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.15802603960037231}],"mesh":[{"descriptor_ui":"D000069455","descriptor_name":"Palivizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000914","descriptor_name":"Antibodies, Viral","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007116","descriptor_name":"Immunization, Passive","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D007223","descriptor_name":"Infant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018113","descriptor_name":"Respiratory Syncytial Virus, Human","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D018357","descriptor_name":"Respiratory Syncytial Virus Infections","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D018357","descriptor_name":"Respiratory Syncytial Virus Infections","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.4161/hv.27426","doi":"https://doi.org/10.4161/hv.27426","is_oa":true,"landing_page_url":"https://doi.org/10.4161/hv.27426","pdf_url":null,"source":{"id":"https://openalex.org/S2483136528","display_name":"Human Vaccines & Immunotherapeutics","issn_l":"2164-5515","issn":["2164-5515","2164-554X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Vaccines & Immunotherapeutics","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3310883","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4130285","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:4130285","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4130285","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hum Vaccin Immunother","raw_type":"Text"},{"id":"pmid:24316863","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24316863","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human vaccines & immunotherapeutics","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.4161/hv.27426","doi":"https://doi.org/10.4161/hv.27426","is_oa":true,"landing_page_url":"https://doi.org/10.4161/hv.27426","pdf_url":null,"source":{"id":"https://openalex.org/S2483136528","display_name":"Human Vaccines & Immunotherapeutics","issn_l":"2164-5515","issn":["2164-5515","2164-554X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Vaccines & Immunotherapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":41,"referenced_works":["https://openalex.org/W1969079131","https://openalex.org/W1975386460","https://openalex.org/W1979156497","https://openalex.org/W1994149977","https://openalex.org/W1995244053","https://openalex.org/W2007290341","https://openalex.org/W2012794057","https://openalex.org/W2016056885","https://openalex.org/W2018672014","https://openalex.org/W2019706667","https://openalex.org/W2022259512","https://openalex.org/W2023227014","https://openalex.org/W2023865002","https://openalex.org/W2029503764","https://openalex.org/W2036975489","https://openalex.org/W2041740968","https://openalex.org/W2041751237","https://openalex.org/W2046119563","https://openalex.org/W2048484118","https://openalex.org/W2050962164","https://openalex.org/W2064906022","https://openalex.org/W2084158088","https://openalex.org/W2084584261","https://openalex.org/W2101114010","https://openalex.org/W2104120073","https://openalex.org/W2108488933","https://openalex.org/W2115260072","https://openalex.org/W2119332183","https://openalex.org/W2120824121","https://openalex.org/W2126163156","https://openalex.org/W2128111454","https://openalex.org/W2134726026","https://openalex.org/W2161945259","https://openalex.org/W2165228626","https://openalex.org/W2318364585","https://openalex.org/W2406423053","https://openalex.org/W2517356996","https://openalex.org/W4245170709","https://openalex.org/W4255267202","https://openalex.org/W4292315834","https://openalex.org/W4301457791"],"related_works":["https://openalex.org/W2955967732","https://openalex.org/W7099332073","https://openalex.org/W4408244583","https://openalex.org/W2052432399","https://openalex.org/W4283708925","https://openalex.org/W2003397209","https://openalex.org/W3107990723","https://openalex.org/W2605198388","https://openalex.org/W1991721489","https://openalex.org/W3164993833"],"abstract_inverted_index":{"Palivizumab":[0],"monthly":[1],"injections":[2],"throughout":[3,148],"the":[4,34,37,43,50,101,119,149],"RSV":[5,22,38,56,150],"season":[6,86],"prevent":[7],"severe":[8],"respiratory":[9],"syncytial":[10],"virus":[11],"(RSV)":[12],"disease":[13],"in":[14,33,80],"preterm":[15],"infants":[16,129],"\u2264":[17],"35":[18],"wGA.":[19],"However,":[20],"some":[21],"guidelines":[23],"currently":[24],"recommend":[25],"stopping":[26],"palivizumab":[27,54,68,81,116],"after":[28],"3":[29],"months":[30,111,140],"of":[31,36,53,63,93,103,112,141],"age":[32,142],"midst":[35],"season.":[39,151],"This":[40],"article":[41],"evaluates":[42],"need":[44],"for":[45,134],"full-season":[46,115],"dosing":[47,87,117,147],"by":[48],"reviewing":[49],"pharmacokinetic":[51],"properties":[52],"and":[55,143],"hospitalization":[57],"(RSVH)":[58],"risk":[59,92,102,133],"as":[60],"a":[61],"function":[62],"chronologic":[64],"age.":[65,113],"Precise":[66],"human":[67],"protective":[69],"levels":[70],"are":[71,130],"not":[72],"established.":[73],"Clinical":[74],"trials":[75],"show":[76],"significant":[77,132],"interpatient":[78],"variability":[79],"serum":[82],"trough":[83],"concentrations.":[84],"Partial":[85],"is":[88],"associated":[89],"with":[90],"increased":[91],"RSVH.":[94,125],"For":[95],"late-preterm":[96,128],"infants,":[97],"data":[98],"suggest":[99],"that":[100],"RSVH":[104,135],"remains":[105],"elevated":[106],"through":[107,136],"at":[108,131,137],"least":[109,138],"6":[110,139],"Monthly,":[114],"provides":[118],"only":[120],"empirically":[121],"proven":[122],"protection":[123],"from":[124,146],"In":[126],"conclusion,":[127],"would":[144],"benefit":[145]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":2},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}